ABIVAX Socit Financials
| AAVXF Stock | USD 18.21 0.00 0.00% |
With this module, you can analyze ABIVAX financials for your investing period. You should be able to track the changes in ABIVAX Socit individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
ABIVAX |
Understanding current and past ABIVAX Socit Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ABIVAX Socit's financial statements are interrelated, with each one affecting the others. For example, an increase in ABIVAX Socit's assets may result in an increase in income on the income statement.
Evaluating ABIVAX Socit's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of ABIVAX Socit's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the ABIVAX Socit's relative financial performance
Chance Of Distress
Over 52
100 | 0 |
ABIVAX Socit Anonyme has more than 52 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for ABIVAX Socit pink sheet is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, ABIVAX Socit's odds of distress score SHOULD NOT be confused with the real chance of ABIVAX Socit Anonyme filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as ABIVAX is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include ABIVAX Socit's liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More InfoThe data published in ABIVAX Socit's official financial statements usually reflect ABIVAX Socit's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of ABIVAX Socit Anonyme. For example, before you start analyzing numbers published by ABIVAX accountants, it's critical to develop an understanding of what ABIVAX Socit's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of ABIVAX Socit's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ABIVAX Socit's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in ABIVAX Socit's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ABIVAX Socit Anonyme. Please utilize our Beneish M Score to check the likelihood of ABIVAX Socit's management manipulating its earnings.
ABIVAX Socit Company Summary
ABIVAX Socit competes with Alvotech, Plexus Corp, Merit Medical, Amkor Technology, and Beyond Air. ABIVAX Socit Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. The company was incorporated in 2013 and is headquartered in Paris, France. Abivax Sa is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 5, rue de |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | NYSE Composite |
| Website | www.abivax.com |
| Phone | 33 1 53 83 08 41 |
| Currency | USD - US Dollar |
You should never invest in ABIVAX Socit without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of ABIVAX Pink Sheet, because this is throwing your money away. Analyzing the key information contained in ABIVAX Socit's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
ABIVAX Socit Key Financial Ratios
Generally speaking, ABIVAX Socit's financial ratios allow both analysts and investors to convert raw data from ABIVAX Socit's financial statements into concise, actionable information that can be used to evaluate the performance of ABIVAX Socit over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that ABIVAX Socit Anonyme reports annually and quarterly.ABIVAX Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ABIVAX Socit's current stock value. Our valuation model uses many indicators to compare ABIVAX Socit value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ABIVAX Socit competition to find correlations between indicators driving ABIVAX Socit's intrinsic value. More Info.ABIVAX Socit Anonyme is number one stock in shares owned by institutions category among related companies. It is number one stock in shares outstanding category among related companies creating about 389,384 of Shares Outstanding per Shares Owned by Institutions. . Comparative valuation analysis is a catch-all model that can be used if you cannot value ABIVAX Socit by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ABIVAX Socit's Pink Sheet . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ABIVAX Socit's earnings, one of the primary drivers of an investment's value.ABIVAX Socit Anonyme Systematic Risk
ABIVAX Socit's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ABIVAX Socit volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifteen with a total number of output elements of fourty-six. The Beta measures systematic risk based on how returns on ABIVAX Socit Anonyme correlated with the market. If Beta is less than 0 ABIVAX Socit generally moves in the opposite direction as compared to the market. If ABIVAX Socit Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ABIVAX Socit Anonyme is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ABIVAX Socit is generally in the same direction as the market. If Beta > 1 ABIVAX Socit moves generally in the same direction as, but more than the movement of the benchmark..
About ABIVAX Socit Financials
What exactly are ABIVAX Socit Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include ABIVAX Socit's income statement, its balance sheet, and the statement of cash flows. Potential ABIVAX Socit investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although ABIVAX Socit investors may use each financial statement separately, they are all related. The changes in ABIVAX Socit's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ABIVAX Socit's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze ABIVAX Socit Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as ABIVAX Socit is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of ABIVAX has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if ABIVAX Socit's financials are consistent with your investment objective using the following steps:- Review ABIVAX Socit's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand ABIVAX Socit's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare ABIVAX Socit's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if ABIVAX Socit's stock is overvalued or undervalued.
ABIVAX Socit September 26, 2023 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ABIVAX Socit help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ABIVAX Socit Anonyme. We use our internally-developed statistical techniques to arrive at the intrinsic value of ABIVAX Socit Anonyme based on widely used predictive technical indicators. In general, we focus on analyzing ABIVAX Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ABIVAX Socit's daily price indicators and compare them against related drivers.
| Information Ratio | 0.0669 | |||
| Maximum Drawdown | 30.16 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABIVAX Socit Anonyme. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in commodities. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for ABIVAX Pink Sheet analysis
When running ABIVAX Socit's price analysis, check to measure ABIVAX Socit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABIVAX Socit is operating at the current time. Most of ABIVAX Socit's value examination focuses on studying past and present price action to predict the probability of ABIVAX Socit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABIVAX Socit's price. Additionally, you may evaluate how the addition of ABIVAX Socit to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |